GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » North China Pharmaceutical Co Ltd (SHSE:600812) » Definitions » Inventories, Finished Goods

North China Pharmaceutical Co (SHSE:600812) Inventories, Finished Goods : ¥0 Mil (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is North China Pharmaceutical Co Inventories, Finished Goods?

North China Pharmaceutical Co's quarterly finished goods increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥1,466 Mil) but then declined from Dec. 2023 (¥1,466 Mil) to Mar. 2024 (¥0 Mil).

North China Pharmaceutical Co's annual finished goods increased from Dec. 2021 (¥1,260 Mil) to Dec. 2022 (¥1,275 Mil) and increased from Dec. 2022 (¥1,275 Mil) to Dec. 2023 (¥1,466 Mil).

North China Pharmaceutical Co Inventories, Finished Goods Historical Data

The historical data trend for North China Pharmaceutical Co's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

North China Pharmaceutical Co Inventories, Finished Goods Chart

North China Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,202.81 1,362.89 1,260.47 1,275.39 1,466.27

North China Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,404.86 - 1,466.27 -

North China Pharmaceutical Co Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

North China Pharmaceutical Co (SHSE:600812) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » North China Pharmaceutical Co Ltd (SHSE:600812) » Definitions » Inventories, Finished Goods
Comparable Companies
SZSE:002038 SZSE:300363 SHSE:600252 SZSE:000756 SHSE:688321 SZSE:002219 SZSE:000915 SHSE:600664 SZSE:002581 SHSE:600789 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
No. 388 Heping East Road, Shijiazhuang, Hebei, CHN, 050015
Website
http://www.ncpc.com
North China Pharmaceutical Co Ltd is engaged in the manufacture and sale of antibiotics, vitamins, and pharmaceutical products in China. The main products include antibiotics such as penicillin, vitamins, cephalosporins, streptomycin, biotechnological drugs, new preparations, and biological products.
Executives
Gao Ren Long senior management
Lian Fa Zhe Director

North China Pharmaceutical Co (SHSE:600812) Headlines

No Headlines